Office of Research

Enabling SUD Digital Therapeutics Research to Improve Payor Adoption (R44- Clinical Trial Only)

Limited Submissions

This Funding Opportunity Announcement is intended to provide targeted funding for systematic research and/or clinical experimentation activities to collect sufficient, to the payors, evidence on the therapeutic value of digital therapeutics for substance use disorders, excluding the alcohol use disorder.

Application Instructions

Please submit:

  1. A one‐page letter of intent with a description of proposed aims and approach.
  2. If the final application requires a diversity statement or statement of broader impacts, please summarize your plans to address the specific requirements on an additional page.
  3. CV (not NIH format) of the PI

to limitedsubs@uw.edu by 5:00 PM Wednesday, October 5, 2022.

Opportunity Details

Program web page

Program Announcement No.

RFA-DA-23-018

Deadlines
10/05/2022 UW Internal Deadline Closed
11/03/2022 OSP Deadline
11/15/2022 Sponsor Deadline
Sponsor

National Institutes of Health (NIH)

Maximum Number of Applications

3 (NIH will not accept similar grant applications with essentially the same research focus from the same applicant organization.)

Eligible groups
  • All campus

Inquiries and Contact Information

Investigators who identify a grant, award or fellowship program that restricts the number of applications that can be submitted from an Institution should immediately contact their Chairperson, Associate Dean for Research (or Dean, if no ADR) and the Office of Research (see below) if they intend to prepare a response. Failure to do so, or to meet the deadlines for submission of pre-proposal, will preclude submission of the application through the Office of Sponsored Programs.

For general inquiries, or to request a listing of a limited submission opportunity that should be but is not already listed, please email us at limitedsubs@uw.edu.